EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS139-21075 
Organism
Homo sapiens 
Tissue/cell
Myotube 
Coordinate
chr16:57072820-57073690 
Target genes
Number of super-enhancer constituents: 10             
IDCoordinateTissue/cell
SE_11963chr16:57072918-57077391CD3
SE_14630chr16:57072917-57077398CD4_Memory_Primary_7pool
SE_17381chr16:57066883-57082158CD4p_CD25-_CD45RAp_Naive
SE_17854chr16:57067875-57077830CD4p_CD25-_CD45ROp_Memory
SE_18287chr16:57066429-57082555CD4p_CD25-_Il17-_PMAstim_Th
SE_19158chr16:57072732-57077916CD4p_CD25-_Il17p_PMAstim_Th17
SE_20292chr16:57068938-57077863CD56
SE_22354chr16:57066432-57077812CD8_primiary
SE_53602chr16:57072066-57077799Spleen
SE_62349chr16:56999188-57080637Tonsil
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr165707312857073339
Number: 1             
IDChromosomeStartEnd
GH16I057035chr165706917857077707
Enhancer Sequence
TGGGAGACAG AGCAAGACTC TGTCTCAAAT TAAAAAAAAA AAAAAAAAAA GAGAGAGCAT 60
GGTATATATA ATCTGTTCCC ATCAATAATG ATCAAGTATT AATAATTATT TGTCATCCCT 120
GCTTCTAGCC CTTAAAAAAC TAATGTTTAA AAAGAGAATC TATAGTTTAA TCCCATGTTT 180
GTAAAACAAA AATTATTGCA CTAGAAAATG GAAGGTTTGA AGGACTCACT CCAAAGGTTA 240
CCAGGGGTAA TCCACACATA CTTTGAGCAC AGACAGAACA CTGACTAGCA GAGAGAGGGG 300
TTTCAGTCTG GGGCTAAAAG AGAGAACACA GAATTTGTTT TCTTTTAAGA CTTGCCAGGA 360
AATGGGGCTT ACTTAGGCAA TAGATACATT TGTGAAATAT CTGTGGTAGA AAGATTTCAG 420
CCCTCCAAAA GCTCAGAGGA AGTCAGAGGG GAGTCAGAGG AAGTGGCTGC AGCTGGAGGC 480
AGGGGGATGG AACTTGAGAG GTCCTCCCGG GCCAGGGGTA AAAAGTGACA GGCCGGGCAC 540
GGTGGCTCAC ACCTATCATC CCAGCACTTT GGGAAGCAAA GGTGGGAGGA TCACCTGAGC 600
CCAGAAGTTC GAGACCAGAG TAGACAACAT AGACTGTCTC TACATACTTT TTTTTTTAAT 660
TAGCTGGGCC TGATGGCACA AGCCTGTAAT CCCAGCTACT CAGGAGGCTG AAGTGGGAGG 720
ATTGCTTGAG CCCAGGAGGT GGAGGCTTCA GTGAGCCATG ATTGCACCAC TGCACACCAG 780
CTTGGGCAAC AGACTGAGAC CTTCTCTCAA AAAGAAATAG TAACAGGGAG CCAATAACCT 840
CTCGCTTCCT CACCCCTCTT TTGTCTTCAC 870